| Literature DB >> 30254862 |
Kazu Ueda1, Yoko Nagayoshi1, Ayako Kawabata1, Takafumi Kuroda1, Yasushi Iida1, Motoaki Saitou1, Nozomu Yanaihara1, Kouhei Sugimoto1, Masaru Sakamoto2, Aikou Okamoto1.
Abstract
OBJECTIVE: Higuchi's transverse incision is made at a lower position than the Pfannenstiel transverse incision and is superior in terms of cosmetic outcomes. The purpose of this study was to examine the safety and efficacy of novel forms of reduced port surgery for ovarian cysts and uterine fibroids applying Higuchi's transverse incision.Entities:
Keywords: laparoscopically assisted myomectomy; power morcellator; reduced port surgery
Year: 2016 PMID: 30254862 PMCID: PMC6113963 DOI: 10.1016/j.gmit.2016.05.003
Source DB: PubMed Journal: Gynecol Minim Invasive Ther ISSN: 2213-3070
Figure 1L-SILS applying Higuchi’s transverse incision. (A) The skin incision made at the superior margin on the pubis. (B) The platform is placed in the 2–3-cm Higuchi’s transverse incision. Three trocars are attached to the EZ access. L-SILS = low-position single-incision laparoscopic surgery.
Figure 2Dual-port LAM applying Higuchi’s transverse incision. (A) The 5-mm trocar for the videoscope is inserted through the umbilicus by the optical method. The platform is placed in the 3-cm Higuchi’s transverse incision above the pubis. Two trocars are attached to the EZ access. (B) The enucleated fibroid from the uterus is collected into an isolation bag, manually morcellated with a scalpel in the bag, and removed from the abdominal cavity via the Higuchi’s transverse incision. LAM = laparoscopically assisted myomectomy.
Characteristics and perioperative outcomes of ovarian cysts.
| L-SILS ( | TLC( | ||
|---|---|---|---|
| Age (y) | 31 (19–42) | 33 (24–44) | 0.077 |
| Body mass index | 19.8 (15.8–24.1) | 19.6 (18.4–24.4) | 0.77 |
| Histologic type | <0.01 | ||
| Teratoma | 28 (84.8) | 17 (32.1) | |
| Endometriotic | 3 (9.1) | 31 (58.5) | |
| Others | 2 (6.1) | 5 (9.4) | |
| Tumor site | 0.725 | ||
| Unilateral | 23 (69.7) | 35 (66.0) | |
| Bilateral | 10 (30.3) | 18 (34.0) | |
| Anesthesia | 0.983 | ||
| GA | 13 (39.4) | 21 (39.6) | |
| GA + TAP/EP | 20 (60.6) | 32 (60.4) | |
| Tumor size (cm) | 9.3 (4.0–21.0) | 8.4 (3.4–17.8) | 0.264 |
| Surgical time (min) | 110.8 (72–167) | 140.5 (76–243) | <0.01 |
| Aeroperitoneum time (min) | 30.1 (7–92) | 109.8 (55–219) | <0.01 |
| Estimated blood loss (g) | 20.6 (0–340) | 42.3 (0–450) | 0.234 |
| CRP (mg/dL) | 1.29 (0.13–3.57) | 1.43 (0.14–6.43) | 0.604 |
| VAS | |||
| Rest | 20.7 (0–52) | 22.1 (0–88) | 0.710 |
| Motion | 43.4 (7–83) | 48.7 (0–100) | 0.245 |
| Postoperative hospital stay (d) | 4.1 (3–6) | 4.0 (3–6) | 0.446 |
Values are presented as mean (range) or n (%).
CRP = C-reactive protein on the next day; GA = general anesthesia; L-SILS = low-position single-incision laparoscopic surgery; TAP/EP = transversus abdominis plane block/epidural anesthesia; TLC = total laparoscopic cystectomy; VAS = visual analog scale on the next day.
a Statistical analysis was performed using the Student t test or the chi-square test. A p value < 0.05 was considered statistically significant.
Comparison of unilateral ovarian cysts.
| L-SILS ( | TLC ( | pa | |
|---|---|---|---|
| Tumor size (cm) | 8.38 (4.0–17.4) | 6.65 (3.4–13.4) | 0.036 |
| Surgical time (min) | 103.5 (72–130) | 127.2 (76–193) | <0.01 |
| Aeroperitoneum time (min) | 28.2 (7–84) | 90.1 (55–159) | <0.01 |
| Estimated blood loss (g) | 3.3 (0–30) | 26.5 (0–250) | 0.086 |
Values are presented as mean (range).
L-SILS = low-position single-incision laparoscopic surgery; TLC = total laparoscopic cystectomy.
a Statistical analysis was performed using the Student t test. A p value < 0.05 was considered statistically significant.
Characteristics and perioperative outcomes of uterine fibroids.
| 2P-LAM ( | conventional LAM | pa | |
|---|---|---|---|
| Age (y) | 34 (33–40) | 38 (31–47) | 0.148 |
| Body mass index | 19.6 (17.9–22.2) | 20.7 (17.0–24.9) | 0.215 |
| Number of fibroids | 0.801 | ||
| 1 | 4 (57.1) | 5 (45.5) | |
| 2 | 1 (14.3) | 3 (27.3) | |
| ≥3 | 2 (28.6) | 3 (27.3) | |
| Tumor size (cm) | 7.04 (6.5–8.7) | 7.57 (5.8-10.4) | 0.604 |
| Surgical time (min) | 204.1 (140–260) | 194.3 (147–237) | 0.579 |
| Aeroperitoneum time (min) | 96.7 (46–141) | 86.8 (52–167) | 0.532 |
| Estimated blood loss (g) | 100 (0–280) | 227.7 (0–970) | 0.274 |
| Hb (g/dL) | 10.6 (9.7–11.5) | 10.8 (8.8–13.9) | 0.710 |
| CRP (mg/dL) | 2.26 (0.84–2.98) | 3.45 (0.83–9.05) | 0.205 |
| Postoperative hospital stay (d) | 4.14 (4–5) | 5.09 (4–7) | 0.023 |
Values are presented as mean (range) or n (%).
CRP = C-reactive protein on the next day; Hb = hemoglobin level on the next day; LAM = laparoscopically assisted myomectomy; 2P-LAM = dual-port laparoscopically assisted myomectomy.
Statistical analysis was performed using the Student t test or the chi-square test. A p value of <0.05 was considered statistically significant.